Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Activity of novel deoxyadenosine analogue investigated against human colon tumors

Feb. 23, 1999

Antiproliferative agents from Warner-Lambert act by inhibiting MEK kinase

Feb. 23, 1999

U.S. patent covers fundamental basis of Prolifix's R&D program

Feb. 23, 1999

FDA permits initiation of GlycoDesign's phase I/II study of GD0039 as chemoprotective agent

Feb. 22, 1999

Liposome initiates phase I clinical trial of TLC-ELL-12

Feb. 22, 1999

FDA accepts NDA filing for Evacet

Feb. 22, 1999

Licensing partner sought for development of prohibitin gene-based cancer Rx, Dx

Feb. 22, 1999

Protein farnesyltransferase inhibitors in development at Bristol-Myers Squibb

Feb. 19, 1999

Genzyme's oncology division in-licenses angiogenesis inhibitor for development

Feb. 19, 1999

Idec Pharmaceuticals announces three new cancer research collaborations

Feb. 19, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...